CN Patent
CN102762538B — 合成Xa因子抑制剂的方法
Assigned to Millennium Pharmaceuticals Inc · Expires 2015-11-25 · 10y expired
What this patent protects
本申请描述了制备式II化合物或其药用盐的新方法。在一些实施方案中,该方法用于制备贝曲西班或其药用盐。本申请还描述了包含基本纯的贝曲西班游离碱或其盐的组合物。
USPTO Abstract
本申请描述了制备式II化合物或其药用盐的新方法。在一些实施方案中,该方法用于制备贝曲西班或其药用盐。本申请还描述了包含基本纯的贝曲西班游离碱或其盐的组合物。
Drugs covered by this patent
- Bevyxxa (BETRIXABAN) · Portola Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.